Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes

被引：0
|
作者：
Zemanova, Zuzana [1 ,2 ]
Michalova, Kyra [1 ,2 ]
Brezinova, Jana [3 ]
Lhotska, Halka [1 ,2 ]
Svobodova, Karla [1 ,2 ]
Sarova, Iveta [3 ]
Lizcova, Libuse [1 ,2 ]
Izakova, Silvia [1 ,2 ]
Ransdorfova, Sarka [3 ]
Krejcik, Zdenek [3 ]
Belickova, Monika [3 ]
Siskova, Magda [1 ,2 ]
Jonasova, Anna [4 ]
Neuwirtova, Radana [2 ,5 ]
Zmolikova, Jana [6 ]
Cermak, Jaroslav [3 ]
机构：
[1] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[4] Charles Univ Prague, Dept Med 1, Gen Hosp, Prague, Czech Republic
[5] Charles Univ Prague, Gen Univ Hosp, Dept Med 1, Prague, Czech Republic
[6] CGB Lab, Ostrava, Czech Republic
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
    Feurstein, Simone
    Thomay, Kathrin
    Hofmann, Winfried
    Buesche, Guntram
    Kreipe, Hans
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Schlegelberger, Brigitte
    Goehring, Gudrun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [22] COMPLEX CHROMOSOMAL ABERRATIONS IN BONE MARROW CELLS OF 86 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Zemanova, Z.
    Michalova, K.
    Brezinova, J.
    Lizcova, L.
    Izakova, S.
    Bystricka, D.
    Sarova, I.
    Siskova, M.
    Neuwirtova, R.
    Cerna, O.
    Cermak, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 13 - 14
  • [23] CYTOGENETIC STUDIES IN 69 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    WEH, HJ
    CALAVREZOS, A
    SEEGER, D
    KUSE, R
    HOSSFELD, DK
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (02) : 166 - 172
  • [24] Update on myelodysplastic syndromes (MDS)
    Hector Rodriguez, Jose
    del Lujan Acosta, Irma
    REVISTA MEDICA DE ROSARIO, 2011, 77 (01): : 24 - 41
  • [25] Rigosertib in myelodysplastic syndromes (MDS)
    Raza, A.
    Ali, A. M.
    Reddy, M. V. R.
    Hoffman, B. S.
    Petrone, M. E.
    Maniar, M.
    Pinheiro, R. F.
    Coutinho, D. F.
    Fruchtman, S. M.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 981 - 988
  • [26] The pathogenesis of myelodysplastic syndromes (MDS)
    Platzbecker, Uwe
    Meredyth-Stewart, Michelle
    Ehninger, Gerhard
    CANCER TREATMENT REVIEWS, 2007, 33 : S53 - S58
  • [27] Serum cytokine levels in patients with myelodysplastic syndromes (MDS).
    Allampallam, K
    Shetty, V
    Mundle, S
    Dutt, D
    Reddy, PL
    Alvi, S
    Galili, N
    Saberwal, GS
    Anthwal, S
    Shaikh, MW
    York, A
    Gezer, S
    Venugopal, P
    Raza, A
    BLOOD, 2001, 98 (11) : 269B - 270B
  • [28] Myelodysplastic syndromes (MDS) Preface
    Klimek, Virginia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (01) : 1 - 2
  • [29] CHROMOSOMAL RESULTS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    LESSARD, M
    BRIZARD, A
    GUILHOT, F
    TANZER, J
    BLUT, 1988, 56 (06): : C9 - C9
  • [30] CYTOGENETIC EVOLUTION AND CLONAL COMPOSITION: PROGNOSTIC IMPACT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA FOLLOWING MDS
    Cevik, N.
    Haase, D.
    Schanz, J.
    HAEMATOLOGICA, 2014, 99 : 262 - 262
12345